Literature DB >> 29546944

[Pediatric asthma hospitalization in Chile: 2001-2014].

Ana María Herrera1, Gabriel Cavada Ch2, Jaime Mañalich M3.   

Abstract

Bronchial asthma is the most prevalent chronic disease in children. Every year an important number of asthmatic children is hospitalized for asthma crisis. The magnitude of this problem in Chile is unknown.
OBJECTIVE: To evaluated the asthma hospitalization rate in 5-15 year-old children and evaluate their evolution. PATIENTS AND
METHOD: We calculate the asthma hospitalization rate in children based on data from the National Hospitalization Discharge Registry from the Statistics and Health Information Department of the Ministry of Health (DEIS) and the National Institute of Statistics (INE). We evaluate the evolution of these rates from 2001 to 2014.
RESULTS: We observed a significant increase in the asthma hospitalization rates in children from 3,8 for 10.000 inhabitants in 2001 to 7,8 for 10.000 inhabitants in 2014. The average age was 8,5 years ± 2,7. Male gender was predominant (57,58%) with a mean length of stay of 3 days (range 1-12).
CONCLUSIONS: The actual asthma hospitalization rate in Chile is 7,8 for 10.000 inhabitants for children 5 to 15 years old, with a double increase in this rate during the 14 year period analyzed.

Entities:  

Mesh:

Year:  2017        PMID: 29546944     DOI: 10.4067/S0370-41062017000500005

Source DB:  PubMed          Journal:  Rev Chil Pediatr        ISSN: 0370-4106


  2 in total

1.  Trends in hospital admissions and mortality rates for asthma in Ecuador: a joinpoint regression analysis of data from 2000 to 2018.

Authors:  Angelita Cabrera; Alejandro Rodriguez; Natalia Romero-Sandoval; Sergio Barba; Philip J Cooper
Journal:  BMJ Open Respir Res       Date:  2021-04

2.  Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study.

Authors:  A M Herrera; P Brand; G Cavada; A Koppmann; M Rivas; J Mackenney; H Sepúlveda; M E Wevar; L Cruzat; S Soto; M A Pérez; A León; I Contreras; C Alvarez; B Walker; C Flores; V Lezana; C Garrido; M E Herrera; A Rojas; C Andrades; E Chala; R A Martínez; M Vega; J A Perillán; H Seguel; I Przybyzsweski
Journal:  Allergol Immunopathol (Madr)       Date:  2018-12-27       Impact factor: 1.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.